National Institute of Neurological Disorders and Stroke (NINDS): all 601 studies
Page 6 of 7. Open to participants first (56), then studies with results posted, then the rest; newest registration first within each.
- Study of Brain and Spinal Cord Tumor Growth and Cyst Development in Patients With Von Hippel Lindau DiseaseActive, not recruitingNCT00005902
- Gentamicin Treatment of Muscular DystrophyCompletedNCT00005574Phase 1
- PET Scans in Normal Volunteers and Patients With Fabry DiseaseCompletedNCT00005111
- Study of Brain Activity During Speech Production and Speech PerceptionCompletedNCT00004991
- Randomized Study of Fetal Neurotransplantation for the Treatment of Parkinson's DiseaseStatus unknownNCT00004844Not applicable
- Phase III Double Blind Trial of Valproate Sodium for Prophylaxis of Post Traumatic SeizuresCompletedNCT00004817Phase 3
- Phase II Randomized Pilot Study of Body Weight Support and Treadmill Training for Chronic Thoracic Spinal Cord InjuryCompletedNCT00004812Phase 2
- Methylprednisolone Given by 24-Hour or 48-Hour Infusion Versus Tirilazad for Acute Spinal Cord InjuryCompletedNCT00004759Phase 3
- Phase II Randomized Study of Selective Dorsal Rhizotomy and Physiotherapy Vs Physiotherapy Alone for Spastic DiplegiaStatus unknownNCT00004751Phase 2
- Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Multiple SclerosisCompletedNCT00004744Phase 3
- Genetic Analysis of the Chiari I MalformationCompletedNCT00004738
- Vitamin Therapy for Prevention of StrokeCompletedNCT00004734Phase 3
- Timing of Levodopa Treatment in Parkinson's DiseaseCompletedNCT00004733Phase 3
- Parkinson's Disease Treatment With Coenzyme Q10CompletedNCT00004731Phase 2
- Ketogenic Diet for Child Epilepsy and Seizure ControlCompletedNCT00004729Not applicable
- Aspirin Or Warfarin To Prevent StrokeTerminatedNCT00004728Phase 3
- Antiplatelet Therapy to Prevent Stroke in African AmericansCompletedNCT00004727Phase 4
- Phase II Randomized Study of Stereotactic Radiosurgery Plus Fractionated Whole-Brain Radiotherapy Vs Fractionated Whole-Brain Radiotherapy Alone for Multiple Primary or Metastatic Brain TumorsStatus unknownNCT00004659Phase 2
- Phase III Randomized, Double-Blind, Sham-Controlled Study of Plasma Exchange for Acute Severe Attacks of Inflammatory Demyelinating Disease Refractory to Intravenous MethylprednisoloneStatus unknownNCT00004645Phase 3
- Study of LY300164 for the Treatment of Parkinson's DiseaseCompletedNCT00004576Phase 2
- Electromyography to Diagnose Neuromuscular DisordersCompletedNCT00004553Not applicable
- Determinants of Disease Severity in Amyotrophic Lateral SclerosisStatus unknownNCT00004457
- Study of Phenotype and Genotype Correlations in Patients With Contiguous Gene Deletion SyndromesCompletedNCT00004351
- Phase III Randomized Study of Diazepam Vs Lorazepam Vs Placebo for Prehospital Treatment of Status EpilepticusCompletedNCT00004297Phase 3
- Oxandrolone Compared With a Placebo on Growth Rate in Girls With Growth Hormone-Treated Turner's SyndromeCompletedNCT00004275Phase 2
- Effect of Estrogen on Mental and Social Functioning in Girls With Turner's SyndromeCompletedNCT00004274Not applicable
- 1-Octanol to Treat Essential TremorCompletedNCT00001986Phase 1
- PET Scan of Brain Metabolism in Relation to Age and DiseaseCompletedNCT00001972
- Electrical Muscle Stimulation to Aid Swallowing in DysphagiaCompletedNCT00001936
- Zenapax to Treat Multiple SclerosisCompletedNCT00001934Phase 2
- Nefiracetam in the Treatment of Alzheimer's DiseaseCompletedNCT00001933Phase 2
- Serotonin Receptors in Seizure DisordersCompletedNCT00001932
- Treatment of Parkinson's Disease With a Transdermal Skin PatchCompletedNCT00001931Phase 2
- Treatment of Huntington's Chorea With AmantadineCompletedNCT00001930Phase 2
- Treatment of Parkinson's Disease With EliprodilCompletedNCT00001929Phase 2
- Intravenous Levodopa for the Diagnosis of Parkinson's DiseaseCompletedNCT00001928
- Study of Abnormal Blood Clotting in Children With StrokeCompletedNCT00001927
- The Connection Between Areas in the Brain of Blind PatientsCompletedNCT00001926
- Effect of Alcohol on TremorsCompletedNCT00001925Phase 2
- Transcranial Magnetic Stimulation for the Treatment of Phantom PainCompletedNCT00001923Phase 1
- Sensory Function in Idiopathic Voice DisordersCompletedNCT00001922
- Study of Attention Deficit/Hyperactivity Disorder Using Transcranial Magnetic StimulationCompletedNCT00001915
- Recombinant Human Interferon Beta-1a (Avonex) for the Treatment of Patients With HTLV-1-Associated Myelopathy (HAM)CompletedNCT00001785Phase 2
- Mexiletine for the Treatment of Focal DystoniaCompletedNCT00001784Phase 2
- Motor Recovery in Recent Stroke Patients Treated With Amphetamine and Physical TherapyCompletedNCT00001783Phase 2
- Areas of Brain Responsible for Understanding American Sign LanguageCompletedNCT00001782
- Safety, Tolerability, and Effectiveness of CGP77116 in Patients With Multiple Sclerosis (MS)CompletedNCT00001781Phase 2
- Magnetic Stimulation of the Human Nervous SystemCompletedNCT00001780
- Sertraline for the Treatment of Patients With Frontal Lobe Dementia (FLD)CompletedNCT00001777Phase 1
- Effects of Brain Stimulation on Learning and ReasoningCompletedNCT00001776
- Vasodilation in Patients With Fabry's DiseaseCompletedNCT00001774
- Language Localization Using Repetitive Transcranial Magnetic Stimulation (rTMS) in Patients With EpilepsyCompletedNCT00001672
- The Classification and Cause of Leukodystrophies of Unknown CauseCompletedNCT00001671
- A 48-Week (24-Week Baseline Followed by a 24-Week Treatment) Phase II Pilot Study of the Tolerability and Effect/Efficacy of Subcutaneously Administered Insulin-Like Growth Factor-1 (rhIGF) (CEP-151) in Multiple Sclerosis (MS) PatientsCompletedNCT00001669Phase 2
- Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac TumorsCompletedNCT00001668
- Genotype/Phenotype Correlation of Movement Disorders and Other Neurological DiseasesCompletedNCT00001667
- Transcranial Magnetic Stimulation for the Treatment of Poorly Controlled Partial EpilepsyCompletedNCT00001666
- Transcranial Magnetic Stimulation for the Treatment of Parkinson's DiseaseCompletedNCT00001665
- Sleep Disorders of Patients With Diseases of the Nervous SystemCompletedNCT00001664
- Treatment of Cortical Myoclonus With Repetitive Transcranial Magnetic StimulationCompletedNCT00001663Phase 1
- Treatment of Alzheimer's Disease With CX516 (Ampalex)CompletedNCT00001662Phase 2
- Mechanisms of Human Plasticity in the Human SystemCompletedNCT00001661
- Infrared Camera for Brain Mapping During SurgeryCompletedNCT00001554Phase 1
- Motor Changes Associated With Recovery From Stroke After TherapyCompletedNCT00001553
- Characteristics of Idiopathic Familial Voice DisordersCompletedNCT00001552
- Characteristics of Idiopathic Familial Speech DisordersCompletedNCT00001551
- Intravenous Immunoglobulin (IVIg) for the Treatment of Stiff-Man Syndrome (SMS)CompletedNCT00001550Phase 1
- Diagnosis and Natural History Study of Patients With Neurological ConditionsCompletedNCT00001549
- Analysis of the Nervous System in Patients With Fabry's DiseaseCompletedNCT00001491
- Effect of Vigabatrin on Brain Blood Flow and Glucose MetabolismCompletedNCT00001489
- PET Scan in Patients With Neurocardiologic DisordersCompletedNCT00001418
- Direct Injection of Alcohol for the Treatment of Spinal TumorsCompletedNCT00001417
- Bone Response to Enzyme Replacement in Gaucher's DiseaseCompletedNCT00001416Phase 2
- Potential Risk Factors for StrokeCompletedNCT00001368Phase 1
- Diagnosis and History Study of Patients With Different Neurological ConditionsCompletedNCT00001367
- Mapping the Areas of the Brain Associated With Language in Children With EpilepsyCompletedNCT00001366
- Dextromethorphan for the Treatment of Parkinson's Disease and Similar Conditions of the Nervous SystemCompletedNCT00001365Phase 2
- Evaluation and Treatment of Patients Spinal Blood Vessel AbnormalitiesCompletedNCT00001364
- PET Scan to Map the Areas of the Brain Involved in PlanningCompletedNCT00001363
- Magnetic Resonance Imaging for the Study of Patients With Neurological DisordersCompletedNCT00001362
- Magnetic Resonance Imaging Studies of Motor and Thought ProcessesCompletedNCT00001361
- Study of Norepinephrine Levels and Sympathetic Nervous System ActivityCompletedNCT00001329
- Gene Therapy for the Treatment of Brain TumorsCompletedNCT00001328Phase 1
- Establishing the Physiology of SyringomyeliaCompletedNCT00001327
- Metabolic Abnormalities in Children With EpilepsyCompletedNCT00001325
- PET Scan to Study Brain Control of Human MovementCompletedNCT00001324
- Effects of Enzyme Replacement in Gaucher's DiseaseCompletedNCT00001289
- Brain Blood Flow Studies of Language and MemoryCompletedNCT00001288
- Intravenous Immunoglobulin (IVIg) for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)CompletedNCT00001287Phase 2
- Intravenousimmunoglobulin (IVIg) for the Treatment of Inflammatory MyopathiesCompletedNCT00001261Phase 2
- Genetic Studies in Alzheimer's DiseaseCompletedNCT00001235
- Gene Therapy for Gaucher's and Fabry Disease Using Viruses and Blood-Forming CellsCompletedNCT00001234Phase 1
- Non-Invasive Electrical Stimulation of the Human BrainCompletedNCT00001216
- Evaluation of Neuromuscular DiseaseCompletedNCT00001201
- Study of "Post-Polio Syndrome"CompletedNCT00001185
- Brain Study of Patients With Frontal Lobe Dementia and Parkinsonian DisordersTerminatedNCT00001178
- Evaluation of Factors in Human Brain TumorsCompletedNCT00001171
- Assessment of Patients With Multiple Sclerosis (MS)CompletedNCT00001156
- Monitoring Patients With Uncontrolled EpilepsyCompletedNCT00001149
- Detecting Malignant Brain Tumor Cells in the Bloodstream During Surgery to Remove the TumorCompletedNCT00001148
← National Institute of Neurological Disorders and Stroke (NINDS) overview and focus areas